haloperidol and cp 293019

haloperidol has been researched along with cp 293019 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chappie, TA; Collins, JL; Desai, KA; Duignan, DB; Dunaiskis, AR; Faraci, WS; Fliri, AF; Jackson, ER; Johnson, CG; Lee, JS; Majchrzak, MJ; Morrone, JM; Prete Di, CC; Sanner, MA; Seymour, PA; Trozzi, A; Zorn, SH	1
Hopkins, CR; Lindsley, CW	1

Reviews

1 review(s) available for haloperidol and cp 293019

Article	Year
Return of D Journal of medicinal chemistry, 2017, 09-14, Volume: 60, Issue:17 Topics: Animals; Drug Discovery; Humans; Ligands; Molecular Targeted Therapy; Neoplasms; Parkinson Disease; Receptors, Dopamine D4; Small Molecule Libraries; Substance-Related Disorders	2017

Other Studies

1 other study(ies) available for haloperidol and cp 293019

Article	Year
Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist. Bioorganic & medicinal chemistry letters, 1998, Apr-07, Volume: 8, Issue:7 Topics: Animals; Apomorphine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Design; Haloperidol; Indicators and Reagents; Molecular Structure; Motor Activity; Pyrazines; Pyrimidines; Rats; Receptors, Dopamine D4; Structure-Activity Relationship	1998

Article

Year

Synthesis, SAR and pharmacology of CP-293,019: a potent, selective dopamine D4 receptor antagonist.

Bioorganic & medicinal chemistry letters, 1998, Apr-07, Volume: 8, Issue:7

Topics: Animals; Apomorphine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Design; Haloperidol; Indicators and Reagents; Molecular Structure; Motor Activity; Pyrazines; Pyrimidines; Rats; Receptors, Dopamine D4; Structure-Activity Relationship

1998